Trends of Incidence and Survival of Brain Metastases from Lung Cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: advanced lung cancer
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The 1-year survival rate for brain metastases in NSCLC patients increased rapidly (APC: 6.47% [5.43%-7.78%]), whereas in SCLC it increased slowly (APC: 1.86% [-1.08% to 5.06%]). [CONCLUSION] The incidence of brain metastases from lung cancer was decreasing, while the survival time was increasing at different rates.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.6%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[BACKGROUND] Brain metastases are common complications in patients with advanced lung cancer.
APA
Zhang C, Zhang H, Jia W (2026). Trends of Incidence and Survival of Brain Metastases from Lung Cancer.. World neurosurgery, 205, 124636. https://doi.org/10.1016/j.wneu.2025.124636
MLA
Zhang C, et al.. "Trends of Incidence and Survival of Brain Metastases from Lung Cancer.." World neurosurgery, vol. 205, 2026, pp. 124636.
PMID
41238059 ↗
Abstract 한글 요약
[BACKGROUND] Brain metastases are common complications in patients with advanced lung cancer. However, the incidence and prognosis of brain metastases from lung cancer remained vague and outdated. Hence, we sought to analyze trends in the incidence and prognosis of brain metastases from lung cancer from 2010 to 2021.
[METHODS] The Surveillance, Epidemiology, and End Results Program (SEER) registry was queried to identify lung cancer patients with known brain metastases status diagnosed between 2010 and 2021. Age-adjusted incidence and median survival were presented in different demographic groups, and the annual percentage change (APC) was calculated.
[RESULTS] The age-adjusted incidence of brain metastases from non-small cell lung cancer (NSCLC) was 4.60 per 100,000, and was 0.87 per 100,000 from small cell lung cancer (SCLC). The incidence of brain metastases from lung cancer has been decreasing, which was consistent with the declining trend of incidence in primary lung cancer. The proportion of brain metastases was higher in male, younger, and Asian patients with lung cancer. The median survival of brain metastases was 5.0 (4.9-5.1) months in NSCLC and 6.0 (5.8-6.2) months in SCLC. Asian patients with brain metastases from NSCLC exhibited better prognosis (median survival: 11.0 [10.3-11.7] months). The 1-year survival rate for brain metastases in NSCLC patients increased rapidly (APC: 6.47% [5.43%-7.78%]), whereas in SCLC it increased slowly (APC: 1.86% [-1.08% to 5.06%]).
[CONCLUSION] The incidence of brain metastases from lung cancer was decreasing, while the survival time was increasing at different rates.
[METHODS] The Surveillance, Epidemiology, and End Results Program (SEER) registry was queried to identify lung cancer patients with known brain metastases status diagnosed between 2010 and 2021. Age-adjusted incidence and median survival were presented in different demographic groups, and the annual percentage change (APC) was calculated.
[RESULTS] The age-adjusted incidence of brain metastases from non-small cell lung cancer (NSCLC) was 4.60 per 100,000, and was 0.87 per 100,000 from small cell lung cancer (SCLC). The incidence of brain metastases from lung cancer has been decreasing, which was consistent with the declining trend of incidence in primary lung cancer. The proportion of brain metastases was higher in male, younger, and Asian patients with lung cancer. The median survival of brain metastases was 5.0 (4.9-5.1) months in NSCLC and 6.0 (5.8-6.2) months in SCLC. Asian patients with brain metastases from NSCLC exhibited better prognosis (median survival: 11.0 [10.3-11.7] months). The 1-year survival rate for brain metastases in NSCLC patients increased rapidly (APC: 6.47% [5.43%-7.78%]), whereas in SCLC it increased slowly (APC: 1.86% [-1.08% to 5.06%]).
[CONCLUSION] The incidence of brain metastases from lung cancer was decreasing, while the survival time was increasing at different rates.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- M-Shaped Auricular Cartilage Grafts for Correcting Short Nose Deformity in Asians: A Retrospective Study.
- Cartilage 3D bioprinting for rhinoplasty using adipose-derived stem cells as seed cells: Review and recent advances.
- Advancing and Lengthening Genioplasty in Contouring of the Receding and Short Chin.
- Role and clinical importance of lactylation in tumors (Review).
- Deep learning-assisted metabolic fingerprint profiling based on V-groove and wrinkle-shaped 3D surface-enhanced Raman scattering substrate for early colorectal cancer diagnosis.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.